Contents 2 min read
Claim and source comparison
Curcumin: pharmacokinetics with piperine, a cognition trial and safety reports.
· Bounded source comparison; not a complete clinical review or independent medical endorsement.
Human pharmacokinetic study
In the 1998 study, serum levels in the 8 analyzed volunteers were very low or undetectable after 2 g of curcumin alone. Levels were higher within the first hour when 20 mg of piperine was added.
These short-term measurements do not establish clinical benefit, long-term safety or equivalence with other formulations.
Source 2 · Full text read
Human randomized controlled trial
In the 2016 trial, 160 people were randomized to 1500 mg/day of Biocurcumax or placebo, and data from 96 were analyzed. Cognitive measures did not differ between groups at 12 months. A temporary decline in the placebo arm at 6 months contributed to the MoCA time-by-group interaction.
Many participants were excluded from the analysis. The findings are specific to this formulation and do not establish dementia prevention.
Source 5 · Full text read
Official safety summary
NIH NCCIH notes reports of liver injury with enhanced-bioavailability curcumin products. It advises stopping the product and seeking medical care if signs such as jaundice or dark urine appear.
These reports do not establish the frequency of injury for each product or a safe absorption threshold.
Source 6 · Official summary read
Human case report / case review
Medsafe reported that the INR of a person taking warfarin rose above 10 after starting a product containing turmeric.
A single report does not establish how often the interaction occurs or whether all products carry the same risk.
Source 7 · Official summary read
Correction · 2026-11-11. Formulation rankings, a general dose and half-life were removed. Sources were added for the cognition trial’s analyzed sample and the liver and warfarin warnings.
What is Curcumin?
Curcumin (Curcuma longa) is a yellow-orange polyphenol obtained from the root part of the turmeric plant. This compound, chemically known as diferuloylmethane, is the active molecule that gives turmeric its characteristic color and has been used in Indian cuisine and Ayurvedic medicine for thousands of years.
Bioavailability Problem
In the 1998 study, serum levels in the 8 analyzed volunteers were very low or undetectable after 2 g of curcumin alone. Levels were higher within the first hour when 20 mg of piperine was added.
These short-term measurements do not establish clinical benefit, long-term safety or equivalence with other formulations.
Clinical Evidence
Sanmukhani et al. (2014) compared curcumin, fluoxetine or their combination in 60 depression patients for 6 weeks; there was no placebo arm. A nonsignificant between-group difference does not prove equivalence or justify replacing an antidepressant with curcumin.
Cox and colleagues’ 2015 trial studied 400 mg of a solid lipid formulation in 60 healthy older adults. At 4 weeks, the study found differences on working memory and some mood measures. These results apply to the study formulation and population.
In the 2016 trial, 160 people were randomized to 1500 mg/day of Biocurcumax or placebo, and data from 96 were analyzed. Cognitive measures did not differ between groups at 12 months. A temporary decline in the placebo arm at 6 months contributed to the MoCA time-by-group interaction.
Dose information and research limits
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
Safety and Side Effects
NIH NCCIH notes reports of liver injury with enhanced-bioavailability curcumin products. It advises stopping the product and seeking medical care if signs such as jaundice or dark urine appear.
Medsafe reported that the INR of a person taking warfarin rose above 10 after starting a product containing turmeric.
A single report does not establish how often the interaction occurs or whether all products carry the same risk.
Related research and reading
These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.
Educational guides
- Brain Aging: Limits of Nootropic Research
NMN, resveratrol and other compounds are studied for aging mechanisms; no nootropic protocol has been established to slow cognitive decline in humans.
- Gut-Brain Axis and Cognitive Performance
The brain makes decisions, but the gut also talks. It has now become one of the most exciting areas of research in neuroscience, where the gut microbiome, which consists of billions of microorganisms, can affect mood, anxiety level and cognitive performance. The evidence is still developing – but the picture is quite striking.
Sources
- Sanmukhani J, et al. (2014). Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytotherapy Research, 28(4), 579–585. PubMed · PMID 23832433
- Shoba G, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353–356. PubMed · PMID 9619120
- Cox KH, et al. (2015). Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Journal of Psychopharmacology, 29(5), 642–651. PubMed · PMID 25277322
- Lopresti AL, et al. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167, 368–375. PubMed · PMID 25046624
- Rainey-Smith SR, et al. (2016). Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. British Journal of Nutrition, 115(12), 2106–13. https://doi.org/10.1017/S0007114516001203 PubMed · PMID 27102361
- NIH NCCIH. Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric NIH NCCIH
- Medsafe. (2018). Beware turmeric/curcumin containing products can interact with warfarin. https://medsafe.govt.nz/safety/ews/2018/Turmeric.asp Medsafe
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
Curcumin is a turmeric polyphenol. Human findings on cognition and mood are mixed; BDNF and amyloid mechanisms do not establish Alzheimer’s prevention. Products with enhanced bioavailability have been linked to liver injury.
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
NIH NCCIH notes reports of liver injury with enhanced-bioavailability curcumin products. It advises stopping the product and seeking medical care if signs such as jaundice or dark urine appear.
No established timeframe
Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.